Mar 21 2008
I’m attending the American College of Cardiology annual meeting in Chicago today and tomorrow. There is a lot of attention being paid to new antithrombotics beyond rivaroxiban and dabigatran. There are at least 10 new anti-Xa and 5 new direct thrombin inhibitor antithrombotics in clinical trials. I’ll provide new information on this subject when I return home on Thursday, April 3. Geo.
No comments here.